The c-Kit (CD117), receptor tyrosine kinase (RTK), and its ligand stem cell factor (SCF) are necessary for the development of embryos and the progression of human cancer. In gastrointestinal stromal ...
HONG KONG – South Korean biotech Novelty Nobility Inc. has attracted ₩10 billion (US$9 million) in series A funding to develop therapeutic antibodies inhibiting the stem cell factor (SCF)/c-KIT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results